CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Telix Partners With Ekalia to Develop US Astatine-211 Production

By Public Technologies
  • Telix Pharmaceuticals partnered with Ekalia, an IBA-Framatome joint venture, to develop scalable U.S. astatine-211 production.
  • The collaboration secures long-term, priority isotope access for its alpha therapy pipeline, including TLX102-Tx for glioblastoma and leptomeningeal disease.
  • The first IBA alpha-beam cyclotron will be installed at the RLS Radiopharmacies site in Trevose, near Philadelphia.
  • The partners will evaluate additional RLS installations as demand develops, with production capacity also intended for third-party academic and industry programs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610190130PRIMZONEFULLFEED9848109) on October 19, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk